Form 4: Tarsus Pharmaceuticals Director William J. Link Reports Share Disposals and Distributions

Director William J. Link reports disposals and distributions of Tarsus Pharmaceuticals shares, both directly and indirectly, through Flying L Partners XI, LLC and Link Family Enterprise, LP.

Summary

• William J. Link, a director of Tarsus Pharmaceuticals, reported transactions involving the company's common stock on August 12, 2024.
• These transactions included an in-kind pro-rata distribution of 74,892 shares by Flying L Partners XI, LLC to its partners.
• Link also acquired 10,446 shares indirectly through Link Family Enterprise, LP, and 27,116 shares directly.
• Additionally, Link disposed of 29,979 shares at an average price of $26.01 and 5,021 shares at an average price of $26.53.
• Following these transactions, Link directly owns 167,098 shares and indirectly owns shares through Flying L Partners XI, LLC and Link Family Enterprise, LP.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company's future prospects.

Key Dates